as mentioned in cnbc
'No one's more frustrated than me' about EpiPen price furor
'No one's more frustrated than me' about EpiPen price furor
In a wide-ranging interview, Heather Bresch, Mylan CEO sits CNBC's Brian Sullivan to discuss the controversy surround the recent 400-percent increase in the EpiPen and her frustration with the health care system.Mylan CEO Heather Bresch struggled Thursday to justify the repeated big price hikes of the company's lifesaving EpiPen devices as criticism continued that Mylan is gouging consumers with a retail cost of more than $600."No one's more frustrated than me," Bresch told CNBC's "Squawk Box" on Thursday when she was pressed on the question of why Mylan needed to have such a high price for EpiPens, and why she just didn't cut their price.
moreover from fosters
EpiPen price hike hurts families
EpiPen price hike hurts families
EXETER — EpiPens may be only one in a series of products that have seen dramatic price increases, made on the decisions of pharmaceutical company management, but the outcry over the huge price hike is partly because of the impact this decision has on families.EpiPen (epinephrine injection) works by narrowing blood vessels and opening airway paths in the lungs following a severe allergic reaction (anaphylaxis), potentially preventing death."It is a life-saving medication," said Jeff Gwinn, director of pharmacy at Anna Jaques Hospital in Newburyport, Massachusetts.
in the same way unionvilletimes
Op/Ed: Government to blame for EpiPen price hikes?
Op/Ed: Government to blame for EpiPen price hikes?
No comments:
Post a Comment